Breast cancer gene patents: the Canadian story

Last week, a Salt Lake City-based company, Myriad Genetics, filed patent infringement suits in Utah court alleging two other U.S. companies are infringing on its patents for BRCA1 and BRCA2, human breast cancer susceptibility genes.

But the story really dates back to the days before rapid gene sequencing when isolating a gene was challenging and painstaking research. Dozens of scientists were feeling their way along human chromosome 17 and later chromosome 13, drawing up the roadmaps as they went. In the process, they invented genetic cloning techniques and followed their hunches in a frenzied search for the mutation that cursed some women.

Read the full article here: Breast cancer gene patents: the Canadian story

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend